Uveitis is inflammation inside the eye that can cause redness, pain, light sensitivity, and blurry vision. Many people with uveitis notice floaters or aching that worsens with bright light, and early symptoms of uveitis may be subtle. It can be short-lived or recurrent, and some forms become long-term without treatment. Uveitis affects children and adults, and not everyone will have the same experience. Treatment often includes prescription eye drops or oral medicines to reduce inflammation, and severe untreated uveitis can threaten vision but is rarely life-threatening.
Overview
UveitisSymptoms
Uveitis often causes eye redness, aching pain, light sensitivity, and blurry vision. Early symptoms of uveitis may also include floaters, reduced vision, and headache, sometimes in one eye, with discomfort worsening in bright light.
Outlook and prognosis
Many people with uveitis do well when treatment starts early and inflammation stays controlled. Vision often stabilizes, though flare-ups can recur and may require ongoing care. Prompt follow-up lowers the risk of complications like glaucoma, cataract, or retinal damage.
Causes and risk factors
Uveitis can stem from autoimmune diseases (like ankylosing spondylitis or sarcoidosis), infections (herpes zoster, tuberculosis, syphilis, Lyme), or eye injury/surgery. Uveitis risk rises with HLA‑B27–related genes, family history, smoking, certain medicines, and uncontrolled systemic inflammation.
Genetic influences
Genetics plays a modest role in uveitis, varying by type. Certain gene variants, especially HLA-B27, raise risk and shape patterns like recurrent anterior inflammation. Family history can guide testing and prognosis, but infections, autoimmune disease, and triggers also matter.
Diagnosis
Uveitis is diagnosed with a detailed eye exam, usually with slit-lamp and dilated pupil checks, plus eye pressure measurement. Doctors may order blood tests or imaging to look for causes and rule out infection. Diagnosis of uveitis prevents vision loss.
Treatment and drugs
Uveitis is managed by calming eye inflammation, easing pain, and protecting vision. Doctors often use steroid eye drops or injections, dilating drops for comfort, and, when needed, oral steroids or immune‑modifying medicines; antibiotics or antivirals treat infections. Regular follow‑up adjusts therapy and prevents flares.
Symptoms
Eye symptoms can interrupt simple routines like looking at a bright screen, stepping into sunlight, or reading. Early symptoms of uveitis often include eye redness, a deep ache, and blurred vision, sometimes in just one eye. You might notice small changes at first, like floaters or a sharper sensitivity to light. Symptoms can build over hours to days and may come and go.
One eye may look pink or bloodshot. The white part can turn red, especially near the colored circle. Redness often grows worse in bright light.
A dull, deep ache in or around the eye is common. It may worsen with focusing or in bright light. The eye can feel tender to the touch.
With uveitis, bright rooms, sunlight, or screens may feel harsh or painful. People often squint or reach for sunglasses indoors. This can make driving or computer work harder.
In uveitis, vision can look smudged or out of focus. Blinking or rubbing does not clear it. Blurring can come and go through the day.
How people usually first notice Uveitis?
Many people first notice uveitis as a sudden, deep ache in one eye, along with redness that doesn’t clear with usual allergy or dryness drops and sensitivity to light that makes screen time or going outside uncomfortable. Vision can blur, and some see new floaters—tiny dark spots or threads drifting across their view—often prompting an urgent eye check. Because these first signs of uveitis can mimic conjunctivitis (“pink eye”) but feel more painful and light-sensitive, seeking prompt care is important to protect vision.
Types of Uveitis
Uveitis affects the eye’s middle layer and can look different from person to person day to day. Some notice sudden pain and light sensitivity; others mainly see floaters or blurry vision that creeps in over weeks. Clinicians often describe them in these categories: by where the inflammation sits in the eye and by how quickly it starts and how long it lasts. Knowing the main types of uveitis can help you and your eye doctor match symptoms to the right treatment, and understand the common types of uveitis by location and timing.
Anterior uveitis
Pain, redness, and light sensitivity tend to come on quickly. Vision may blur, and the pupil can look smaller due to spasm. Flares often respond well to prompt treatment.
Intermediate uveitis
Blurred vision and lots of floaters are more common than pain. The front of the eye can look normal while inflammation sits deeper. People may notice waxing and waning symptoms over months.
Posterior uveitis
Vision changes, dark spots, or distortion are typical because the retina and choroid are involved. Pain and redness are often mild or absent. It can threaten central vision if not treated.
Panuveitis
Inflammation spans the front and back of the eye. Symptoms can mix—pain and redness with floaters and significant blur. This type often needs more than one form of treatment.
Acute uveitis
Symptoms start suddenly over hours to days. Pain, light sensitivity, and redness are common in the acute anterior form. Vision often improves with quick treatment.
Chronic uveitis
Inflammation persists for 3 months or more or returns soon after tapering drops. Many notice fluctuating blur and recurring floaters more than pain. Long-term control aims to prevent flare-ups and protect vision.
Unilateral vs bilateral
One eye may be affected at a time, or both together. One type may be strong for a while, then fade as another emerges. Patterns can hint at underlying causes and guide testing.
Infectious uveitis
Caused by an infection such as toxoplasmosis, herpes viruses, or tuberculosis. Symptoms vary by site but often include floaters and focal vision blur in posterior disease. Treatment targets the infection plus inflammation.
Noninfectious uveitis
Driven by immune or inflammatory conditions like sarcoidosis or ankylosing spondylitis. Some notice joint or skin symptoms alongside eye flares. Therapy often uses anti-inflammatory drops, pills, or targeted biologics.
What genetics can tell you about symptoms
Certain HLA gene types, especially HLA‑B27, link to uveitis that starts suddenly, causes eye pain, light sensitivity, and blurred vision, and often recurs. Other variants like HLA‑A29 tie to birdshot chorioretinopathy, leading to night vision trouble, floaters, and color changes.
Causes and risk factors
Uveitis often comes from autoimmune disease, infections, or eye injury or surgery, but sometimes no cause is found.
Risk is higher with autoimmune disease, including some arthritis, bowel inflammation, sarcoidosis, or Behçet disease.
A gene marker called HLA‑B27 and family history can raise the chance of uveitis.
Smoking, some medicines, weak immunity, and recent eye surgery or trauma can trigger or worsen inflammation.
Talk with your doctor if you’re concerned about your risks or early symptoms of uveitis.
Environmental and biological risk factors
Uveitis is inflammation inside the eye that can flare suddenly or smolder over time, affecting comfort and vision. Doctors often group risks into internal (biological) and external (environmental). Early symptoms of uveitis, like eye pain, redness, light sensitivity, and blurry vision, can make daily tasks hard, from reading screens to driving at night. Below are key biological and environmental factors that can raise the chance of an episode.
Disorders such as ankylosing spondylitis, psoriatic arthritis, inflammatory bowel disease, sarcoidosis, or Behçet disease raise the risk of uveitis. During a flare, the immune system may mistakenly inflame the uvea and nearby tissues.
Viruses, bacteria, or parasites like herpes viruses, tuberculosis, syphilis, toxoplasma, or Lyme disease can trigger uveitis. The eye may inflame due to germs present in or near the eye, or from the immune reaction they set off.
Blunt impact, penetrating injury, or a retained foreign body can lead to uveitis. Inflammation may begin soon after the injury or emerge weeks later.
Procedures such as cataract or glaucoma surgery, retinal procedures, or intraocular injections can be followed by uveitis. Healing responses or, rarely, postoperative infection can spark inflammation.
Genetic risk factors
Genes play a major role in who is more likely to develop uveitis, particularly through immune system markers called HLA types. Carrying a genetic change doesn’t guarantee the condition will appear. Researchers have mapped several genetic risk factors for uveitis that point to how the immune system recognizes the eye. Understanding these markers can help explain why certain patterns run in families and vary by ancestry.
HLA-B27 type: This immune gene type is strongly linked to acute anterior uveitis. People who carry HLA-B27 have a higher chance of sudden, painful eye inflammation that can recur. Doctors may confirm this with a blood test if the uveitis pattern fits.
HLA-B51 (Behçet): This HLA type raises the risk of uveitis in people with Behçet disease. It is especially tied to more severe eye inflammation and vision-threatening flares. Rates and strength of this link vary by ancestry.
HLA-A29 (birdshot): HLA-A29 is present in nearly all people with birdshot chorioretinopathy, a chronic form of posterior uveitis. Carrying HLA-A29 alone does not mean you will develop this rare condition. Genetic testing may be considered when the clinical picture suggests birdshot.
HLA-DRB1*04 types: Certain DRB1*04 subtypes, such as DRB1*0405, increase risk for Vogt–Koyanagi–Harada–related uveitis. This link is strongest in East Asian and Latin American populations. It influences how the immune system reacts to eye and pigment tissues.
ERAP1/ERAP2 changes: Variants in ERAP genes can interact with HLA types like HLA-B27 or HLA-A29 to raise uveitis risk. These genes help process proteins for the immune system. The combination of ERAP changes and specific HLA types appears to shape who develops certain uveitis patterns.
IL23R variants: Changes near the IL23R gene, part of an inflammation pathway, are linked to noninfectious uveitis. They seem to affect how strongly the immune system drives eye inflammation. Effects are modest on their own but add up with other risks.
NOD2 mutations: Rare, inherited changes in NOD2 cause Blau syndrome/early-onset sarcoidosis, which often includes childhood uveitis. These mutations lead to granulomatous inflammation that can involve the eyes, skin, and joints. Families with this pattern may benefit from genetic counseling.
Family history: Having close relatives with uveitis or related immune conditions suggests shared genetic susceptibility. The risk increase is usually small to moderate, not absolute. Patterns can differ between families and uveitis subtypes.
Ancestry background: Because HLA types cluster by ancestry, some forms of uveitis occur more often in certain populations. This reflects genetic background rather than behaviors or environment. Knowing ancestry can help doctors interpret HLA results and tailor monitoring.
Lifestyle risk factors
Uveitis can be shaped by day-to-day choices that influence inflammation, infection exposure, and injury risk. While many cases are autoimmune or infectious, lifestyle factors can affect flare frequency, severity, and how well treatments work. Below are practical, evidence-informed lifestyle risk factors for uveitis and how lifestyle affects uveitis. Understanding the lifestyle risk factors for uveitis can help you reduce preventable triggers.
Smoking is linked to higher risk and severity of noninfectious uveitis and poorer treatment response. Quitting may lower flare frequency and complications like macular edema.
Diets high in ultra-processed foods and sugars can drive systemic inflammation that may worsen autoimmune uveitis activity. Anti-inflammatory patterns (vegetables, omega-3-rich fish, nuts, legumes) may support calmer disease.
Low vitamin D has been associated with higher autoimmune activity and uveitis relapses in some studies. Adequate dietary intake or supplementation per clinician guidance may reduce flare risk.
Regular moderate exercise lowers systemic inflammatory markers and may help reduce uveitis relapse risk. It can also support metabolic health, which improves treatment response.
Risk prevention
Uveitis can’t always be prevented, because it often stems from infections, autoimmune activity, or eye injury. You can lower the chance of flares and long-term vision problems by protecting your eyes, staying on top of care for any related health conditions, and acting early if symptoms start. Prevention works best when combined with regular check-ups. Knowing early symptoms of uveitis helps you act quickly if it returns.
Wear safety glasses for home projects, yard work, or contact sports to prevent eye injuries that can trigger uveitis. Sunglasses can also reduce light sensitivity when your eyes are irritated.
Keep up with rheumatology or gastroenterology care if you live with conditions like arthritis or inflammatory bowel disease. Taking medicines as prescribed lowers inflammation that can drive uveitis.
If you’re eligible, get the shingles vaccine to reduce the risk of zoster-related eye inflammation. Many adults 50 years and older benefit from this protection.
See a clinician promptly for shingles, cold sores near the eye, or any serious infection. Quick treatment lowers the chance the inflammation will involve the eye.
Transmission
Uveitis is inflammation inside the eye and is not contagious—you can’t catch it from someone, and it doesn’t spread through casual contact. In many people, it’s driven by the immune system or follows an injury or eye surgery; these causes don’t transfer between people. Occasionally an infection such as herpes, shingles, tuberculosis, or syphilis can trigger uveitis, and those germs have their own ways of spreading, but having uveitis itself does not make you infectious.
It also doesn’t jump from one eye to the other by touch; when both eyes are involved, it’s because the underlying condition affects both. If you’re worried about how uveitis is transmitted, ask your clinician whether an infection is suspected and whether any specific precautions are needed.
When to test your genes
Consider genetic testing if you have recurrent or unexplained uveitis, especially with back pain, psoriasis, inflammatory bowel disease, or a family history of these; HLA‑B27 and a few others can guide care. Test sooner with severe, bilateral, or steroid‑dependent flares. Results won’t diagnose uveitis alone but can tailor monitoring and treatment.
Diagnosis
Red, aching eyes, light sensitivity, and blurry vision often bring people in for an urgent eye check. Doctors usually begin with a careful conversation and a focused eye exam to pinpoint where the inflammation is and what might be driving it. This is how uveitis is diagnosed in practice: by combining what you feel with what the eye exam shows, and adding targeted tests when an underlying cause is suspected. Sometimes the cause is found quickly; other times, it takes a few visits.
Your eye doctor asks when symptoms started, which eye is affected, and if there is pain, light sensitivity, floaters, or blurred vision. They also review past episodes, infections, medications, and whole‑body symptoms that could point to a cause.
A standard eye chart checks how clearly you see at distance and near. Pupil tests can hint at irritation inside the eye and help pick up complications that might affect the optic nerve.
A special microscope lets the doctor look for inflammatory cells and other signs in the front of the eye. This helps confirm active uveitis and shows whether the inflammation is mild or severe.
A quick tonometry test measures intraocular pressure. It helps detect pressure changes from inflammation or steroid treatment that could harm the optic nerve if not addressed.
Stages of Uveitis
Uveitis does not have defined progression stages. Symptoms and findings can flare and settle over time, and the condition is grouped more by where inflammation occurs in the eye than by a stepwise stage. Different tests may be suggested to help confirm uveitis and look for a cause, including a detailed eye exam with a microscope light, checking the back of the eye after dilating the pupil, and sometimes scans or blood tests. If you notice early symptoms of uveitis—such as eye pain, redness, light sensitivity, or blurry vision—an eye specialist can assess and monitor changes over time.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, and with uveitis the answer depends on how quickly it’s treated and what’s causing the inflammation. Vision usually improves when treatment starts early, but flares can recur. Severe pain, light sensitivity, or new floaters that don’t settle are early symptoms of uveitis that should prompt urgent care, because untreated inflammation raises the risk of glaucoma, cataract, macular swelling, and permanent vision loss.
Prognosis refers to how a condition tends to change or stabilize over time. For many living with uveitis, the long-term outlook is good with consistent treatment and regular eye checks, especially when the cause is limited to the eye and responds to drops or injections. If uveitis is part of an autoimmune disease or linked to infections, the course can be more variable and may require immune-suppressing medicines for months to years. Most people with uveitis do not face life-threatening illness; mortality is uncommon and usually tied to an underlying systemic condition rather than the eye inflammation itself.
With ongoing care, many people maintain stable vision and normal daily activities, though some will have periodic flares that need quick adjustment of therapy. Children and those with chronic, quiet inflammation can have fewer obvious symptoms, so scheduled screening is key to protect sight. Knowing what to expect can ease some of the worry, and it helps to remember that treatment plans often evolve over time to balance control of inflammation with side effects. Talk with your doctor about what your personal outlook might look like, including how often to follow up, signs of a flare, and steps to reduce complications.
Long-term effects
Uveitis can leave lasting effects on vision and eye health, especially if flares are frequent or treatment is delayed. Long-term effects vary widely, depending on the part of the eye involved, how quickly flares are treated, and any underlying immune condition. Prompt care during a flare and regular eye checks can lower the chance of permanent changes. For many, this long view focuses on protecting vision and preventing complications over time.
Repeated or severe inflammation can damage delicate eye tissues and reduce vision. Permanent vision loss is uncommon with early diagnosis and consistent care.
Fluid can build in the central retina and blur straight‑ahead vision. Colors and fine details may seem washed out or wavy.
Long‑term inflammation or steroid eye drops can raise eye pressure. Ongoing high pressure can harm the optic nerve and narrow side vision over time.
Inflammation and steroid treatment can cloud the lens earlier than expected. This often causes glare, halos, and trouble seeing at night.
How is it to live with Uveitis?
Living with uveitis can feel unpredictable, with eye pain, light sensitivity, and blurry vision flaring up and settling down in cycles that disrupt work, driving, and screen time. Many find they plan their day around sunglasses, eye drops, and follow-up appointments, and during flares may need to rest their eyes more, reduce reading, or avoid bright environments. Treatment—often steroid drops or other immune-calming medicines—can help protect vision, but it requires consistency and monitoring for side effects, which adds to the routine. People around you may notice you wearing shades indoors or needing extra patience with pace and lighting, and their understanding can make it easier to keep up with everyday life while protecting long-term vision.
Treatment and drugs
Treatment for uveitis focuses on calming inflammation quickly, easing pain, and protecting vision. Doctors often start with steroid eye drops; for more severe or back-of-the-eye inflammation, you may need steroid injections, oral steroids, or immune‑modulating drugs such as methotrexate or biologic medicines to reduce the body’s overactive immune response. If infection is the cause, targeted antibiotics or antivirals are used instead of, or alongside, steroids, and your eye specialist will monitor eye pressure and the lens to prevent complications like glaucoma or cataract. Treatment plans often combine several approaches, and the dose is tapered carefully to avoid flare‑ups while limiting side effects. Keep track of how you feel, and share this with your care team, especially if you notice changes in vision, eye pain, or new floaters, as early symptoms of uveitis flares can be subtle.
Non-drug treatment
Non-drug care for uveitis focuses on easing light sensitivity and pain, protecting the eye, and supporting everyday vision while medical treatment calms inflammation. Non-drug treatments often lay the foundation for comfort and day-to-day function. Knowing early symptoms of uveitis—like sudden light sensitivity, aching eye pain, or a new blurry spot—can help you seek prompt care. These steps are usually used alongside your eye doctor’s plan and tailored to how your eyes feel during a flare.
Polarized sunglasses and a brimmed hat cut glare and ease light sensitivity. This can make driving or being outdoors more comfortable during a flare. Choose lenses with full UV protection.
Short, regular breaks reduce strain from screens and reading. Dimming room lights can also lower discomfort when eyes are inflamed. Avoid driving at night if glare worsens pain.
A clean, gently cooled or warm compress can soothe aching around the eye. Use light pressure only and keep the eyelid closed. Stop if it increases discomfort.
Preservative-free artificial tears can relieve dryness and stinging. Avoid “redness-relief” drops, which may irritate sensitive eyes. Ask which formulations are safest for frequent use.
Your genes may have an impact on how drugs work for you
Think of treatment like fitting a key to a lock: small genetic differences can change how the lock turns. Variants in drug-processing enzymes and immune pathways can alter response, side effects, and dosing needs for steroids, immunomodulators, and biologics in uveitis.
Pharmacological treatments
Treatment for uveitis aims to calm inflammation fast, protect vision, and prevent flare-ups. Early symptoms of uveitis like light sensitivity and eye pain are often eased quickly by anti-inflammatory eye drops, while deeper or recurrent inflammation may need pills, injections, or biologic medicines. Plans are tailored to whether the cause is noninfectious or due to an infection. Not everyone responds to the same medication in the same way.
Prednisolone acetate or dexamethasone drops reduce inflammation and light sensitivity in the front of the eye. Loteprednol is a milder option that may have fewer pressure effects.
Atropine or cyclopentolate relax the eye’s focusing muscle to reduce pain and prevent the iris from sticking to the lens. These can also help light sensitivity while inflammation settles.
Prednisone tablets calm more widespread or stubborn inflammation, or involvement beyond the front of the eye. Short courses are common; high-dose methylprednisolone may be used briefly for severe flares.
Periocular or intravitreal triamcinolone targets inflammation inside the eye when drops aren’t enough. Long-acting implants like dexamethasone (Ozurdex) or fluocinolone can help recurrent cases.
Genetic influences
Some types of uveitis have a genetic component that affects how the immune system behaves inside the eye. Genetics is only one piece of the puzzle, but it can raise the likelihood of flares in people who carry certain immune markers (for example, HLA‑B27) or who have relatives with autoimmune conditions such as ankylosing spondylitis, psoriasis, or inflammatory bowel disease. If there’s a family history of uveitis or these related conditions, your own risk can be higher, though many people never develop symptoms. Rare inherited syndromes can cause early, recurrent uveitis in children, and a few uveitis subtypes are strongly tied to specific genetic patterns, where targeted genetic testing may help confirm the diagnosis. Even when genes nudge risk upward, infections and other environmental factors often influence when inflammation starts or returns. For many, questions like is uveitis genetic or how family history affects treatment are best discussed with an eye specialist and, when needed, a genetic counselor who can clarify what testing can—and cannot—show.
Is Uveitis genetic?
Genetics plays a modest role in uveitis, varying by type. Certain gene variants, especially HLA-B27, raise risk and shape patterns like recurrent anterior inflammation. Family history can guide testing and prognosis, but infections, autoimmune disease, and triggers also matter.
Pharmacogenetics—how genetics influence drug effects
In uveitis care, your genes can influence both which medicines are chosen and how safely you can take them. When uveitis is linked to certain immune-system gene patterns, doctors may lean toward treatments that target the underlying immune pathway (for example, biologic medicines) once infection has been ruled out. Genetic testing can sometimes identify how your body processes specific medicines used in uveitis care. Right now, pharmacogenetic testing for uveitis is most established with thiopurines such as azathioprine: differences in TPMT or NUDT15 can cause dangerously low blood counts at usual doses, so many clinicians check for these and adjust dosing or choose another drug. Corticosteroids are widely used; some people are “steroid responders” who develop higher eye pressure, a tendency that may be influenced by genes, but routine DNA testing isn’t part of care, so regular pressure checks are still key. For biologics like adalimumab and for medicines such as methotrexate or mycophenolate, research into genetic predictors is ongoing, and findings aren’t yet strong enough to guide treatment choices on their own.
Interactions with other conditions
Uveitis often occurs alongside autoimmune conditions like arthritis of the spine, psoriasis-related arthritis, inflammatory bowel disease, and sarcoidosis, so eye flares may mirror activity elsewhere in the body. Someone might notice their symptoms flare when another condition is active. In some people, early symptoms of uveitis—eye pain, light sensitivity, and blurry vision—start soon after a skin, joint, or gut flare; in children, it can accompany juvenile arthritis even when the eyes feel quiet. Certain infections (such as tuberculosis, shingles/herpes, syphilis, or toxoplasmosis) can cause uveitis or mimic it, and steroids or other immune-suppressing medicines for non‑eye problems may worsen hidden infections. Treatments can interact in both directions: steroid eye drops or tablets used for uveitis can raise eye pressure or blood sugar, while some medicines for osteoporosis or cancer immunotherapy have been linked to drug‑induced uveitis. Because patterns vary widely, coordinating care between your eye specialist and the clinician managing your other condition helps align treatment and reduce the risk of relapses.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described sudden light sensitivity and aching eyes that made reading, weaving, or tending a fire difficult. In some accounts, vision dulled over days, then cleared, only to blur again months later. These lived experiences match what we now call uveitis, an inflammation inside the eye that can affect one or both eyes and sometimes returns in episodes.
First described in the medical literature as inflammation of the uveal tract, early physicians recognized telltale features: redness that rimmed the iris, pain made worse by bright light, and a small or irregular pupil. Long before modern imaging, doctors used a handheld light and careful observation to spot floating “cells” in the eye’s fluid and a slight haze that signaled active inflammation. Over time, descriptions became more precise, separating uveitis into patterns based on which part of the eye was involved—front (anterior), middle, back (posterior), or the entire eye (panuveitis).
As medical science evolved, links between uveitis and whole‑body conditions came into focus. In the mid‑20th century, clinicians noticed that some people with joint pain or skin rashes also developed eye inflammation. Later, blood tests and imaging helped connect certain types of uveitis with conditions like inflammatory arthritis, infections such as tuberculosis or toxoplasmosis, and, in some cases, no clear cause at all. Advances in genetics added another layer, showing that certain inherited markers, like HLA‑B27, can raise the chance of specific uveitis patterns, especially those that flare quickly in the front of the eye.
Treatment history followed a similar arc. Early care relied on rest, dark rooms, and plant extracts to ease pain and widen the pupil. The introduction of corticosteroid drops in the mid‑1900s changed outcomes dramatically by calming inflammation more directly. From these first observations, therapies expanded to include dilating drops to prevent scar‑like bands inside the eye, steroid injections or tablets for deeper inflammation, and, more recently, steroid‑sparing medicines and targeted biologic drugs for stubborn or recurrent uveitis tied to systemic disease.
Not every early description was complete, yet together they built the foundation of today’s knowledge. Modern eye exams use slit‑lamp microscopes, retinal scans, and wide‑field imaging to track inflammation with far more accuracy than was once possible. This has improved how quickly clinicians can identify early symptoms of uveitis and tailor care to reduce complications like glaucoma, cataract, or swelling at the center of the retina.
With each decade, the picture has become clearer: uveitis is not a single disease but a group of inflammatory patterns with varied triggers and courses. Knowing the condition’s history helps explain why evaluation looks beyond the eye to the whole person—and why timely treatment and follow‑up remain central to protecting sight.